Navigation Links
Harborview Medical Center Implements Latest Release of the DocuSys Solution to Improve Anesthesia Medication Safety and Documentation
Date:3/12/2008

MOBILE, Ala. and SEATTLE, March 12 /PRNewswire/ -- DocuSys, Inc., a leading anesthesia information management system (AIMS) and medication management system provider, today announced that Harborview Medical Center in Seattle, Wash., the only Level I adult and pediatric trauma center serving a four-state region went live yesterday on DocuSys' anesthesia solutions, which will automate the documentation of anesthesia care and enhance the medication management processes in their perioperative (surgical) environment.

In support of its designation as a "Patient Safety Mentor Hospital" for other hospitals in the state of Washington, Harborview Medical Center chose to implement DocuSys' advanced medication safety solution including DocuJect(R), a point-of-care intravenous drug monitoring device, in addition to its AIMS application. DocuJect utilizes digital imaging and bar code scanning to proactively alert the clinician to potential adverse drug reactions. DocuSys' medication safety solutions are focused on enabling healthcare organizations to implement the recommendations outlined in last year's U.S. Pharmacopeia MEDMARX(R) Data Report to reduce perioperative medication error rates.

"We are committed to delivering the safest, most comprehensive anesthesia care to each of our patients, and the addition of the DocuSys solutions enables Harborview Medical Center to more effectively meet this objective," said Dr. Michael Souter, associate professor of Anesthesiology, Neurocritical Care, at Harborview Medical Center and anesthesiology project lead. "Having DocuSys share the anesthesiology record electronically with our electronic medical record system enables Harborview Medical Center to ensure continuity of care."

The ability to share clinical information among clinical system vendors has become a more important requirement over the past few years as healthcare organizations have made decisions to select a best-of-breed solution for key areas like anesthesiology. For Harborview Medical Center, the ability to integrate with their electronic medical record system was a key criterion in selecting DocuSys. According to DocuSys Executive Vice President and Chief Operating Officer, Joseph E. Heins, Pharm.D., the company has the broadest experience of any anesthesia information system vendor in providing this information in both a comprehensive anesthesia record format and as discrete data for key elements of the record.

"Harborview Medical Center is well known within Washington, as well as nationally, for delivering the best possible care to its patients," Heins said. "As the first client live on the latest release of our market-leading solutions, Harborview Medical Center worked closely with DocuSys to ensure the system was carefully configured to meet their advanced requirements. We are proud that Harborview Medical Center recognized the benefits of the DocuSys anesthesia solutions to enable them to augment their high standard of care."

About Harborview Medical Center

Founded in 1877, Harborview Medical Center is one of the region's most comprehensive healthcare facilities, providing high quality, technologically advanced care for everyone regardless of their ability to pay. Owned by King County and managed by the University of Washington, Harborview is the only Level I adult and pediatric trauma center and regional burn center serving the four-state region of Washington, Alaska, Montana and Idaho. In addition to being a "safety net" hospital providing care to the underserved, Harborview is the hospital of choice for many privately insured patients seeking a variety of services, such as neurosurgery, reconstruction and rehabilitation, and orthopedics. For more information, visit http://www.harborview.org .

About DocuSys

DocuSys is a market-leading anesthesia information management system (AIMS) and medication management system provider, maximizing both the quality of care and return on investment in surgery. The company provides solutions that address all stage of the anesthesia care delivery process, including the preadmission evaluation process. Additional benefits of the system include ease of use, billing and charge capture automation and aligning such quality measures as CMS' pay-for-performance (P4P) program with financial objectives. DocuSys' modular design permits integration with existing hospital information systems, electronic medication dispensing cabinets, infusion pumps, physiologic monitors and other systems in those settings where intravenous drug delivery is key. The company has received 510(k) clearance from the Food and Drug Administration (FDA) to market its technology and is a registered medical device manufacturer in accordance with FDA guidelines. http://www.docusys.net .

Contact: Tom Mitchell, Director of Marketing Communications

e-mail: tmitchell@docusys.net

phone: (251)445-1651


'/>"/>
SOURCE DocuSys, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. MSU engineering team designs innovative medical device
2. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
3. Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract
4. Owner and Operator of Florida Durable Medical Equipment Company Convicted of Medicare Fraud
5. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
6. Doctors and medical ethicist discuss whether doctors should participate in capital punishment
7. Preparation for Natural Disasters Critical for People With Diabetes, Chronic Medical Conditions
8. Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment
9. Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments
10. Milestone Scientific Announces Successful Completion of its Collaboration Agreement With Carticept Medical
11. FDA Seeks to Regulate Complementary and Alternative Medicine; Products Such as Vegetable Juice Could Be Restricted for Medical Use
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... ... May 24, 2016 , ... The old expression “a ... problem. A common injury that’s often misunderstood, whiplash should be swiftly diagnosed and treated ... orthopedic spine surgeon at Atlantic Spine Center . , So named because ...
(Date:5/24/2016)... ... 24, 2016 , ... Researchers from Catholic Health Initiatives (CHI) ... bleeding complications from percutaneous coronary intervention (PCI). The data, presented at the annual ... document a 40% reduction in risk-adjusted bleeding event rates over a two-year period ...
(Date:5/24/2016)... ... May 24, 2016 , ... ... web-based software module. The cutting-edge feature provides end users with an embedded, ... self-service business intelligence solution and its analytics engine. , This powerful ...
(Date:5/23/2016)... Akron, Ohio (PRWEB) , ... May 23, 2016 ... ... not-for-profit continuing care retirement community, dedicated its new $11.5 million, 64-room assisted living ... an invitation-only ceremony and ribbon cutting. , The new building provides the ...
(Date:5/23/2016)... ... May 23, 2016 , ... According to an article ... than 1% of United Kingdom residents who could benefit from bariatric surgery are actually ... increases the number of bariatric procedures it offers to obese patients from 6,000 to ...
Breaking Medicine News(10 mins):
(Date:5/19/2016)... 19, 2016 A new report ... Market -Opportunities and Forecasts, 2015 -2022, projects that the ... 2022, registering a CAGR of 5.1% from 2015 to ... be the highest revenue-generating segment throughout the forecast period. ... one-third of the market share in 2015, and is ...
(Date:5/19/2016)... -- The equities market is never short of ... is without doubt the Healthcare space. ActiveWallSt.com has uncovered four ... Alkermes PLC (NASDAQ: ALKS ), AMAG Pharmaceuticals Inc. ... IDXX ), and Atossa Genetics Inc. (NASDAQ: ... http://www.activewallst.com/ On Wednesday, Alkermes PLC,s ...
(Date:5/19/2016)... 19, 2016 MGB Biopharma, ... of Anti-infectives, Welcomes the Final Instalment of Lord ... Today   Lord Jim O,Neill,s ... final recommendations, providing a comprehensive action plan for ... the rising threat of superbugs - something that ...
Breaking Medicine Technology: